Many antimycotic agents negatively affect the natural immune response. Typically, these drugs impair polymorphonuclear leukocyte (PMN) production of superoxide anion, chemotaxis, or the killing of pathogens.
glycol-bis(O-aminoethyl ether)-N,N,N',N'-tetraacetic acid. In the presence of terbinafine or naftifine, chemotaxis of PMNs was not impaired. Terbinafine and naftifine slightly but significantly increased the killing of C. albicans blastospores (P < 0.05 at 10 and 100 ,uM). In conclusion, in contrast to imidazole-like drugs, the allylamine antimycotic compounds terbinafine and naftifine enhance selected functions of PMNs.
Mycoses are usually treated with antifungal drugs. This class of drugs contains many different chemical entities with specific mechanisms of antifungal action (25, 40, 44, 46, 48) . Antifungal drugs may also have immunosuppressive effects, acting on the host's natural or specific immunity (7, 16, 24, 26, 55) . These properties may be harmful in the context of the eradication of fungal infection and may also impair host defenses against other opportunistic infections, especially in immunocompromised patients.
Polymorphonuclear leukocytes (PMNs) are among the most important host effector mechanisms against bacterial and fungal infections. They are activated by soluble factors produced at the infection site. They migrate toward the infected area and recognize the microorganisms, which are phagocytized and killed (3, 4, 12) . Phagocytosis is accompanied by increased oxygen consumption. It is used by PMNs to produce reduced oxygen metabolites such as superoxide anion. This is called the "respiratory burst" (3, 4, 12) .
Antimycotic compounds of the imidazole group (17, 20, 27, 43, 49, 60, (62) (63) (64) negatively affect the natural immune response; Rowan-Kelly et al. (43) showed that clotrimazole, miconazole, and ketoconazole inhibit PMN chemotaxis and that miconazole and ketoconazole also impair the bactericidal and fungicidal actions of PMNs. Ketoconazole and the two new antimycotic drugs in the imidazole group, itraconazole and fluconazole, also affect oxidant production by PMNs; Vuddhakul et al. (62) (63) (64) examined the effects of bifonazole, ICI 195,739, and amorolfine; they showed that all of these drugs inhibit chemotaxis and superoxide anion production in PMNs.
Amphotericin B affects vitality (11) , chemotaxis (8), phago-* Corresponding author.
cytosis (10) , and chemiluminescence and oxidant production (8, 54) and increases the aggregation and adherence of PMNs (6, 9) . Furthermore, it enhances the killing abilities of PMNs or macrophages (2, 5, 15, 19, 31, 33, 37-39, 41, 42, 47, 52, 59, 61, 65) . The ability of amphotericin B to increase the activities of PMNs and macrophages may be the reason for its inflammatory properties (52, 53) . The allylamines (naftifine and terbinafine), a new generation of broad-spectrum antimycotic compounds, have recently been developed; they act by interfering with squalene 2,3-epoxidase, which results in decreased amounts of the principal membrane sterols, especially ergosterol (44, 48) . Naftifine, a topically administered allylamine, has been shown to inhibit PMN function; specifically, naftifine was shown to depress chemotaxis, chemokinesis, chemiluminescence, and superoxide anion production (51) . However, depressant effects were observed at relatively high concentrations (about 30 ,ug/ml), which were associated with a certain amount of selective cytotoxicity against PMNs (51) . Terbinafine is an orally effective allylamine derivative (44) (13) . The PMNs were washed and resuspended in Hanks balanced salt solution (HBSS) at a concentration of 107 cells per ml and were kept in ice-cold buffer until they were used.
Superoxide anion production. The generation of superoxide anion by PMNs was evaluated by spectrophotometric determination of cytochrome c reduction (13, 35) and was inhibitable by superoxide dismutase. The cell suspension was placed in 2-ml polystyrene cuvettes at a final concentration of 1 x 106 to 4 x 106 cells per 2 ml in the presence of 0.08 mM ferricytochrome c and various amounts of stimulants and drugs. The stimulating substances tested were PMA, a direct activator of protein kinase C, and the chemotactic peptide fMLP (3, 4, 12) . Dimethyl sulfoxide (DMSO) was the solvent for the stimulants and was used at a concentration of less than or equal to 0.1%, which did not affect superoxide release in our system. Changes in the A550 were monitored continuously by using a Beckman DU-50 spectrophotometer equipped with water bath-thermostatted cuvette holder at 37°C for up to 10 min after the addition of the stimulus. The amount of superoxide anion produced was calculated by using a molar extinction coefficient of 21.1 mol-1 cm-' (35) .
Chemotaxis. The chemotaxis assay was performed by using a modified Boyden chamber method (23 BI, PMA at 10 nM plus naftifine at 1 ,uM; C1, PMA at 10 nM plus naftifine at 10 jiM; Dl, PMA at 10 nM plus naftifine at 100 ,uM.
fetal calf serum (FCS) at a concentration of 1.5 x 106 PMNs per ml. A two-section chamber (Neuroprobe Inc.) and 5-,umpore-size polycarbonate polyvinylpyrrolidone-free filters (Nuclepore, Pleasanton, Calif.) were used. The lower-chamber wells (negative controls) contained 27 p.l of RPMI 1640-1% FCS-0.1% DMSO; positive controls contained the same medium with 10 nM fMLP, either without or with terbinafine and naftifine at various concentrations. In the upper chamber we placed 75,000 PMNs per well; the PMNs were suspended in RPMI 1640-1% FCS-0.1% DMSO without or with the same concentrations of terbinafine and naftifine used in the lower chamber. Every assay was replicated in six wells. The chamber was incubated for 1 h at 37°C, after which the filter was removed, fixed with methanol and stained with eosin G-thiazine in phosphate buffer (pH 6.6; DiffQuik-Baxter; Dade AG), mounted on a glass slide, and examined by light microscopy. Chemotaxis was evaluated by counting the average number of cells which had migrated through the filter in five x 1,000-magnification microscopic fields (23, 50 
RESULTS
Effects of terbinafine and naftifine on superoxide anion production by PMNs. Preincubation of PMNs with terbinafine or naftifine (0.1 to 100 ,uM) for times ranging from 10 to 60 min on its own did not trigger the release of superoxide anions. However, when we tested the effects of different stimuli, such as 10 nM PMA or 100 nM fMLP, on PMNs preincubated with terbinafine or naftifine for 10 min there was enhancement of the superoxide anion production compared with that by control cells (Table 1 ; Fig. 1 and 2 ). This effect of terbinafine and naftifine, i.e., the drugs' ability to increase superoxide anion production after subsequent appropriate stimuli, is consistent with a "priming" effect. The priming effect of terbinafine and naftifine was significant for three of four doses tested (1, 10, and 100 ,M). For control purposes we also evaluated the priming effect of a known agent (bacterial LPS [100 ng/ml preincubated for 10 min at 37°C]). LPS enhanced superoxide release after stimulation with fMLP and PMA, but LPS did not affect superoxide anion release in unstimulated cells.
Terbinafine, naftifine, and [Ca2+J1 in PMNs. As shown in Fig. 3 and 4 and (Table 2 ).
Terbinafine and chemotaxis. Terbinafine and naftifine did not alter the adherence of PMNs to the polycarbonate filter in the chemotaxis assay and did not exert significant chemotactic activity when they were added to the inferior part of the chamber in the absence of fMLP. At a dose of 10 nM, fMLP stimulated the chemotaxis of PMNs fourfold. Terbinafine and naftifine at doses of 0.1, 1, 10, and 100 ,uM did not interfere with the chemotaxis-stimulating effect of fMLP. The results are reported in Table 3 .
Terbinafine and C. albicans blastospore killing. As reported in Table 4 , terbinafine at doses of 10 and 100 ,uM stimulated increased killing of C. albicans blastospores by PMNs. However, 1 ,uM terbinafine did not modify the killing of C. albicans blastospores by PMNs. Naftifine at 10 and 100 ,uM stimulated increased killing of C. albicans blastospores by PMNs. Terbinafine and naftifine at 100 ,iM did not affect C. albicans blastospore survival when they were tested in the absence of PMNs under the same experimental conditions used in the presence of PMNs (data not shown). We did not evaluate whether terbinafine's effect on yeast survival was due to the adherence of C. albicans to the PMNs, phagocytosis of C. albicans, or the killing of C. albicans following phagocytosis. DISCUSSION Therapeutic concentrations of terbinafine are about 0.8 to 1.5 ,ug/ml in blood (3 ,uM) and are up to 9 ,ug/g of tissue in the stratum corneum (44) . Naftifine is not absorbed by the oral route and is only intended for topical application. Terbinafine and naftifine primed PMNs for the production of superoxide anions, increased the ability of PMNs to kill C. albicans blastospores, and did not depress the stimulated chemotaxis of PMNs. These effects were evident at micromolar concentrations; therefore, they could be of clinical relevance. Many imidazole-type drugs (see introduction) inhibit all or some of these functions in PMNs. The allylamine naftifine has also been shown to inhibit some PMN functions. However, these results were obtained in the presence of relatively high drug concentrations reported by the same authors to be associated with the selective cytotoxicity of PMNs. The cytotoxicity of naftifine was prevented by the addition of bovine serum albumin to the medium (51); under our experimental conditions naftifine did not display cytotoxicity toward PMNs. Other investigators (1) have reported increased levels of superoxide production as a result of terbinafine treatment.
To investigate the mechanism by which terbinafine and naftifine promote the priming of PMNs, we studied the effects (2, 15, 19, 37-39, 47, 54, 59, 61) . These effects were also explained by the enhancement of some neutrophil functions. A possible biochemical link between the augmented killing ability of PMNs and the drug structure depended on the membrane-ruffling effect of amphotericin B; however, miconazole, an imidazolelike drug which depresses PMNs action, has the same biochemical effects as amphotericin B (66) . Further study is necessary to investigate the biochemical basis of the PMN-enhancing activities of amphotericin B and allylamines.
In conclusion, two allylamines, terbinafine and naftifine, in contrast to many imidazole-like antimycotic compounds, potentiate selected functions of human PMNs. It would be interesting to evaluate the proinflammatory activities of these drugs.
